Rita Leporati

12PUBLICATIONS
58CO-AUTHORS
Molecular targetsEarly English languagesCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 31, 2026
From Tumour to Bloodstream: Advancing PD-L1 Testing With Liquid Biopsies in Non-Small Cell Lung Cancer.

|Apr 14, 2026
Exosome Biogenesis: Meta-Analysis of Intraluminal Vesicle Size Across Species.

Sayam Ghosal, Rita Leporati, Bora Yilmaz

|Apr 07, 2026
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry.

Arianna Marinello, Julia K Rotow, Meghanne Lomibao

|Jul 16, 2025
Breast cancer and large-cell neuroendocrine carcinoma harboring the same <i>PIK3CA</i> mutation: A case report.

Emma Zattarin, Teresa Beninato, Giorgia Di Liberti

|Dec 19, 2024
Sex differences in patients with Non-Small Cell Lung Cancer harboring driver fusions treated with tyrosine kinase inhibitors: a systematic review.

Rita Leporati, Édouard Auclin, Daniel Morchón

|Oct 02, 2024
Efficacy of carboplatin-etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis.

Igor Gomez-Randulfe, Sofía Silva Díaz, Carles Escriu

Pageof 2

Frequent Collaborators

4 joint publications

Claudio Vernieri

2 joint publications

Marta Brambilla

2 joint publications

Andrea Vingiani

2 joint publications

Giovanni Fucà